Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Clinical trial NCT03659916 · COMPLETED

Trial details

NCT number: NCT03659916
Sponsor: Albireo, an Ipsen Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Progressive Familial Intrahepatic Cholestasis

Start date: 2018-09-28
Primary completion: 2024-02-15
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.